Epidemiology of drug-resistant HIV-1 transmission in nave patients in Spain;Epidemiología de la transmisión del virus de la inmunodeficiencia humana tipo 1 resistente a antirretrovirales en pacientes naive en España

Medicina Clinica

Volumn 135, Issue 12, 2010, Pages 561-567

  Yebra, Gonzalo ^a   Holguín, África ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

HIV 1; Nave patients; Prevalence; Primary resistance mutations; Spain; Transmission

Indexed keywords

ANTIRETROVIRUS AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

DISEASE TRANSMISSION; GENE MUTATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PREVALENCE; REVIEW; SEROCONVERSION; SEROPREVALENCE; SPAIN; TREATMENT RESPONSE; VIRUS TRANSMISSION;

ANTI-RETROVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; MUTATION; PREVALENCE; SPAIN;

EID: 77957607422     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2009.09.029     Document Type: Review

References (59)

1. Informe sobre la epidemia mundial de Sida, 2008. [consultado 15/9/2009]. Disponible en: http://www.unaids.org/es/KnowledgeCentre/HIVData/GlobalReport/ 2008/2008-Global-report.asp.
2. Vigilancia epidemiolgica del sida en España: valoracin de los nuevos diagnsticos de VIH en España a partir de los sistemas de notificacin de casos de las CCAA. Perodo 20032007. Actualizacin 30 de junio de 2008. [consultado 15/9/2009]. Disponible en: http://www.isciii.es/htdocs/pdf/ nuevos-diagnosticos-ccaa.pdf.
3. Infeccin VIH no diagnosticada: situacin en España. Marzo 2009. [consultado 15/9/2009]. Disponible en: http://www.isciii.es/htdocs/pdf/ InformeVIHNoDiagnosticado.pdf.
4. V.A. Johnson, F. Brun-Vezinet, B. Clotet, H.F. Gunthard, D.R. Kuritzkes, and D. Pillay Update of the drug resistance mutations in HIV-1 Top HIV Med 16 2008 138 145
5. Gua de resistencias a los antirretrovirales 2009: interpretacin de los genotipos de resistencia de la Red de Investigacin en SIDA (RIS) [consultado 15/9/2009]. Disponible en: http://www.retic-ris.net/upload/files/Gua- Resistencias-a-los-Antirretrovirales-200902.pdf
6. Recomendaciones de GeSIDA/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el VIH (actualizacin febrero 2009). [consultado 15/9/2009]. Disponible en: http://www.gesida.seimc. org/pcientifica/fuentes/DcyRc/gesidadcyrc2009-RecomendacionesdeGesida- PNSsobreTARV(febrero2009).pdf.
7. M.S. Hirsch, H.F. Gnthard, J.M. Schapiro, F. Brun-Vzinet, B. Clotet, and S.M. Hammer Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel Clin Infect Dis 47 2008 266 285
8. A.M. Vandamme, A. Snnerborg, M. Ait-Khaled, J. Albert, B. Asjo, and L. Bacheler Updated European recommendations for the clinical use of HIV drug resistance testing Antivir Ther 9 2004 829 848
9. A.M. Wensing, D.A. Van de Vijver, G. Angarano, B. Asj, C. Balotta, and E. Boeri Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: Implications for clinical management J Infect Dis 192 2005 958 966
10. S. Yerly, V. Von Wyl, B. Ledergerber, J. Bni, J. Schpbach, and P. Brgisser Transmission of HIV-1 drug resistance in Switzerland: A 10-year molecular epidemiology survey AIDS 21 2007 2223 2229
11. C.L. Booth, and A.M. Geretti Prevalence and determinants of transmitted antiretroviral drug resistance in HIV-1 infection J Antimicrob Chemother 59 2007 1047 1056
12. A.M. Geretti Epidemiology of antiretroviral drug resistance in drug-nave persons Curr Opin Infect Dis 20 2007 22 32
13. A. Shet, L. Berry, H. Mohri, S. Mehandru, C. Chung, and A. Kim Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: A decade of experience J Acquir Immune Defic Syndr 41 2006 439 446
14. D. Smith, M. Moini, R. Pesano, E. Cachay, H. Aiem, and Y. Lie Clinical utility of HIV standard genotyping among antiretroviral-naive individuals with unknown duration of infection Clin Infect Dis 44 2007 456 458
15. A. Vessire, E. Nerrienet, A. Kfuwah, E. Menu, M. Tejiokem, and P. Pinson-Recordon HIV-1 pol gene polymorphism and antiretroviral resistance mutations in drug-naive pregnant women in Yaound, Cameroon J Acquir Immune Defic Syndr 42 2006 256 258
16. N. Vidal, C. Mulanga, S.E. Bazepeo, J.K. Mwamba, J. Tshimpaka, and M. Kashi HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in the Democratic Republic of Congo (DRC) AIDS Res Hum Retroviruses 22 2006 202 206
17. M. Pérez-Olmeda, J. Del Romero, A. Rubio, L. Ruiz, C. Rodrguez, and M. Leal Primary HIV-1 drug resistance in Spain before and after the introduction of protease inhibitors J Med Virol 63 2001 85 87 (Pubitemid 32142263)
18. C. Briones, M. Pérez-Olmeda, C. Rodrguez, J. Del Romero, K. Hertogs, and V. Soriano Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid J Acquir Immune Defic Syndr 26 2001 145 150
19. C. De Mendoza, C. Rodrguez, J. Colomina, C. Tuset, F. Garca, and J.M. Eiros Resistance to nonnucleoside reverse-transcriptase inhibitors and prevalence of HIV type 1 non-B subtypes are increasing among persons with recent infection in Spain Clin Infect Dis 41 2005 1350 1354
20. De Mendoza C, Rodrguez C, Aguilera A, Garca F, Leiva P, Poveda E, et al. Virological characterization of HIV strains in recent seroconverters in Spain. XVII International HIV Drug Resistance Workshop; 2008 Jun 1014; Sitges, España.
21. th European HIV Drug Resistance Workshop; 2009 Mar 2527; Estocolmo, Suecia.
22. J.M. Eiros, C. Labayru, B. Hernndez, M. Ortega, P. Bachiller, and R. Ortiz de Lejarazu Prevalence of genotypic resistance in untreated HIV patients in Spain Eur J Clin Microbiol Infect Dis 21 2002 310 313
23. J.M. Eiros, R. Blanco, C. Labayru, B. Hernndez, G. Bou, and M. Domnguez-Gil Prevalence of genotypic resistance in untreated HIV-infected patients Rev Esp Quimioter 17 2004 250 256
24. T. Puig, M. Pérez-Olmeda, A. Rubio, L. Ruiz, C. Briones, and J.M. Franco Prevalence of genotypic resistance to nucleoside analogues and protease inhibitors in Spain. The ERASE-2 Study Group AIDS 14 2000 727 732
25. A. Guerrero, A. Caizares, S. Toms, D. Velasco, and M. Cartelle Prevalencia de resistencia a los frmacos antirretrovirales en pacientes espaoles infectados por el VIH y sin tratamiento previo Enferm Infecc Microbiol Clin 23 2005 605 608
26. O. Gallego, L. Ruiz, A. Vallejo, E. Ferrer, A. Rubio, and B. Clotet Changes in the rate of genotypic resistance to antiretroviral drugs in Spain AIDS 15 2001 1894 1896
27. M.J. Rodrguez-Escudero, E. Prada de Medio, C. Rosa Herranz, M.C. Martnez Medina, and R. Franquelo Gutirrez Prevalencia de la resistencia genotpica a los frmacos antirretrovirales en pacientes VIH positivos en la provincia de Cuenca Rev Esp Quimioter 20 2007 203 205
28. J. Garca-Guerrero, P. Siz de la Hoya, J. Portilla, A. Marco, J. Snchez-Pay, and S. Moreno Prevalence of HIV-1 drug resistance mutations among Spanish prison inmates Eur J Clin Microbiol Infect Dis 25 2006 695 701
29. th European HIV Drug Resistance Workshop; 2009 Mar 2527; Estocolmo, Suecia.
30. th European HIV Drug Resistance Workshop; 2006 Mar 2931; Montecarlo, Mnaco.
31. th European HIV Drug Resistance Workshop; 2009 Mar 2527; Estocolmo, Suecia.
32. Mir JM, Pumarola T, Garca F, Arnedo M, Vidal C, Lozano L, et al. Prevalence of transmission of HIV-1 drug resistant mutations in patients with primary HIV-1 infection in Barcelona (Spain). XIII International AIDS Conference; 2000 Jul 914; Durban, Sudfrica.
33. Arnedo M, Mir JM, Fumarola T, Gil C, Claramonte X, Del Ro A, et al. Prevalence of HIV-1 drug resistance mutations in patients with primary HIV-1 infection (PHI) in Barcelona (Spain). XIV International AIDS Conference; 2002 Jul 712; Barcelona, España.
34. L. Pérez-lvarez, R. Carmona, M. Muoz, E. Delgado, M.M. Thomson, and G. Contreras High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: Study of genotypic resistance Antivir Ther 8 2003 355 360
35. th International HIV Drug Resistance Workshop; 2004 Jun 812; Tenerife, España.
36. th International HIV Drug Resistance Workshop; 2005 Jun 711; Qubec, Canad.
37. th European HIV Drug Resistance Workshop; 2006 Mar 29-31; Montecarlo, Mnaco.
38. M. Snchez Ooro, M.J. Lpez, M.A. Santana, J.M. Ands, and F.A. Campelo Resistencias primarias a los frmacos antirretrovirales en los pacientes diagnosticados de infeccin por el VIH en Gran Canaria entre los aos 2002-2005 Enferm Infecc Microbiol Clin 25 2007 437 440
39. R. Palacios, I. Viciana, I. Pérez de Pedro, J. De la Torre, F. Ropero, and S. Fernndez Prevalencia de mutaciones de resistencia primaria en los nuevos diagnsticos de infeccin por el VIH en la provincia de Mlaga Enferm Infecc Microbiol Clin 26 2008 141 145
40. M.J. McConnell, F. Docobo-Pérez, R.C. Mata, F. Fernndez-Cuenca, P. Viciana, and L.F. Lpez-Corts Molecular epidemiology of HIV type 1 in newly diagnosed patients in southern Spain AIDS Res Hum Retroviruses 24 2008 881 887
41. th International Symposium on Infectious in the Immunocompromised Host; 2008 Jun 2225; Tesalnica, Grecia.
42. th European HIV Drug Resistance Workshop; 2009 Mar 2527; Estocolmo, Suecia.
43. H. Green, P. Tilston, E. Fearnhill, D. Pillay, and D.T. Dunn The impact of different definitions on the estimated rate of transmitted HIV drug resistance in the United Kingdom J Acquir Immune Defic Syndr 49 2008 196 204
44. Van de Vijver D, Wensing A, Boucher C. The epidemiology of transmission of drug resistant HIV-1 en "HIV Sequence Compendium 2006/2007". Editado por: Thomas Leitner T, Foley B, Hahn B, Marx P, McCutchan F, Mellors J, et al. Publicado por: Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM. LA-UR 07-4826.
45. C. Briones, and E. Domingo Minority report: Hidden memory genomes in HIV-1 quasispecies and possible clinical implications AIDS Rev 10 2008 93 109
46. HIVdb Program. Genotypic Resistance Interpretation Algorithm, version 6.0.1 [consultado en: 05/06/2009]. Disponible en: http://hivdb.stanford.edu/ pages/algs/HIVdb.html.
47. Agence Nationale de Recherche sur le Sida (ANRS). Algoritmo de interpretacin de resistencias genotpicas a VIH-1. [consultado en: 05/06/2009]. Disponible en: http://www.hivfrenchresistance.org.
48. D.E. Bennett, R.J. Camacho, D. Otelea, D.R. Kuritzkes, H. Fleury, and M. Kiuchi Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update PLoS One 4 2009 e4724
49. A. Holguín, E. Ramrez de Arellano, P. Rivas, and V. Soriano Efficacy of antiretroviral therapy in individuals infected with HIV-1 non-B subtypes AIDS Rev 8 2006 98 107
50. A.M. Geretti HIV-1 subtypes: Epidemiology and significance for HIV management Curr Opin Infect Dis 19 2006 1 7
51. J.L. Martnez-Cajas, N. Pant-Pai, M.B. Klein, and M.A. Wainberg Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: A systematic review of virologic and biochemical evidence AIDS Rev 10 2008 212 223
52. K.J. Metzner, S.G. Giulieri, S.A. Knoepfel, P. Rauch, P. Burgisser, and S. Yerly Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients Clin Infect Dis 48 2009 239 247
53. UK Collaborative Group on HIV Drug Resistance; UK Collaborative HIV Cohort Study; UK Register of HIV Seroconverters Evidence of a decline in transmitted HIV-1 drug resistance in the United Kingdom AIDS 21 2007 1035 1039
54. The SPREAD programme. Transmission of drug-resistant HIV-1 in Europe remains limited to single classes AIDS 22 2008 625 635
55. Leitner T, Korber BT, Daniels M. HIV-1 subtype and circulating recombinant form (CRF) reference sequences, 2005. En: Thomas Leitner T, Foley B, Hahn B, Marx P, McCutchan F, Mellors J, et al. HIV Sequence Compendium 2006/2007. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, NM, LA-UR 06-0680.
56. A. Holguín, M. De Mulder, G. Yebra, M. Lpez, and V. Soriano Increase of non-B subtypes and recombinants among newly diagnosed HIV-1 native Spaniards and immigrants in Spain Curr HIV Res 6 2008 327 334
57. A. Sagir, M. Oette, R. Kaiser, M. Dumer, G. Ftkenheuer, and J.K. Rockstroh Trends of prevalence of primary HIV drug resistance in Germany J Antimicrob Chemother 60 2007 843 848
58. th Conference on Retrovirus and Opportunistic Infections; 2007 Feb 2528; Los Angeles, EE. UU.
59. A. Holguín, M. Lpez, and V. Soriano Reliability of rapid subtyping tools compared to that of phylogenetic analysis for characterization of human immunodeficiency virus type 1 non-B subtypes and recombinant forms J Clin Microbiol 46 2008 3896 3899